Drogasil, TGM Set To Price

Drogasil, a Brazilian pharmaceutical chain, is set to price 22,764,661 ordinary shares in an IPO on Bovespa and in a 144a registered deal in the US today, Thursday. The price range for the sale is between BRL12 and BRL15 a share for a total deal value of $151m, according to Dealogic. UBS Pactual and Bradesco BBI are leading. Logistics firm Tegma Gestão Logísitca is also slated to raise up to $300m in a Brazilian/144a sale of 299,277,606 ordinary shares at an initial price range of BRL26-BRL32 reais. JPMorgan and Unibanco have books.